Skip to main content
. Author manuscript; available in PMC: 2017 Jun 5.
Published in final edited form as: Psychopharmacology (Berl). 2013 May 5;229(1):199–208. doi: 10.1007/s00213-013-3099-4

Table 2.

Treatment Group Means for Psychosocial Questionnaires Pre and Post Treatment

Pre-Treatment
Post-Treatment
Placebo
Oxytocin
Placebo
Oxytocin
STAI
 State 44.5 (6.35) 44.82 (5.75) - -
 Trait 43.55 (4.73) 45.32 (4.26) - -
KSS 5.14 (1.86) 5 (1.88) 4.6 (1.98) 4.64 (1.81)
POMS
 Vigor 21.91 (7.28) 20.36 (6.55) 21.41 (8.51) 21.64 (6.14)
 Tension/Anxietya 11.55 (2.79) 13.05 (5.16) 10.18 (2.34) 10.73 (2.71)
 Depression 15.45 (3.39) 14.91 (1.44) 14.64 (1.59) 14.64 (1.43)
 Anger 13.05 (1.79) 13.91 (2.65) 13 (2.13) 13.36 (2.13)
 Fatiguea 7.91 (2.09) 9.86 (3.48) 7.59 (2.44) 8.31 (2.36)
 Confusion 6.86 (1.25) 7.18 (1.53) 6.86 (1.34) 6.68 (1.46)

Note. Standard deviations in parentheses. STAI = State Trait Anxiety Inventory, KSS = Karolinska Sleepiness Scale, POMS = Profile of Mood States.

a

Tension/Anxiety and Fatigue were significantly reduced (p < .05) at the second test across all treatment groups.